Back to top
more

Cigna Group (CI)

(Delayed Data from NYSE)

$274.90 USD

274.90
1,518,178

+3.90 (1.44%)

Updated Aug 8, 2025 04:00 PM ET

After-Market: $275.00 +0.10 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 5% (231 out of 244)

Industry: Medical - HMOs

Zacks News

Zacks Equity Research

Insurance Stock Q1 Earnings Due on Apr 30: CI, MMC & More

Improved revenues might have driven earnings for insurance stocks in the first quarter of 2020.

Zacks Equity Research

LKQ Corp. (LKQ) to Post Q1 Earnings: What's in the Offing?

Lower vehicle sales amid a weakening consumer demand and soft economic conditions are expected to have hampered LKQ Corp's (LKQ) top line in Q1.

Zacks Equity Research

Is a Surprise Coming for Cigna (CI) This Earnings Season?

Cigna (CI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Zacks Equity Research

Will Membership Growth Drive Cigna's (CI) Earnings in Q1?

Cigna's (CI) Q1 earnings are likely to have been aided by revenue growth in various segments.

Zacks Equity Research

Zacks.com featured highlights include: Keysight Technologies, ResMed, Cigna and Jack Henry & Associates

Zacks.com featured highlights include: Keysight Technologies, ResMed, Cigna and Jack Henry & Associates

Zacks Equity Research

The Zacks Analyst Blog Highlights: Limelight Networks, Chemed, Cigna, CURO Group and Huron Consulting Group

The Zacks Analyst Blog Highlights: Limelight Networks, Chemed, Cigna, CURO Group and Huron Consulting Group

Zacks Equity Research

Add These 4 GARP Stocks to Your Portfolio for Maximum Returns

Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.

Zacks Equity Research

Will Dismal North American Market Hurt Ford's (F) Q1 Earnings?

Declining sales in Ford's (F) North American segment likely to have hurt the company's Q1 bottom line.

Zacks Equity Research

Will Solid Model 3/Y Sales Drive Tesla's (TSLA) Q1 Earnings?

Rise in Tesla's (TSLA) Model 3/Y deliveries likely to have fueled the company's earnings in the first quarter of 2020.

Zacks Equity Research

Cigna (CI) Earnings Expected to Grow: Should You Buy?

Cigna (CI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Harley-Davidson (HOG) to Post Q1 Earnings: What's in Store?

While Harley-Davidson's (HOG) efforts to bolster dealer networks is likely to have aided its revenues in Q1, high SG&A costs and rising competition remain concerns.

Zacks Equity Research

What's in the Offing for Cummins (CMI) This Earnings Season?

Heightening coronavirus fears and elevated R&D expenses are likely to have dragged down Cummins' (CMI) margins in the first quarter.

Nalak Das headshot

5 Top Growth Stocks to Buy Ahead of Q1 Earnings This Month

Five growth stocks with a favorable Zacks Rank that are set to beat first-quarter earnings estimates this month.

Zacks Equity Research

What's in the Offing for Tesla (TSLA) This Earnings Season?

While increasing Model 3 deliveries are likely to have aided Tesla's (TSLA) revenues in the first quarter, rising R&D and SG&A costs are concerns.

Zacks Equity Research

How Badly Will Coronavirus Hit Ford's (F) Q1 Earnings?

Amid coronavirus outbreak and stay-at-home orders in multiple states, Ford (F) anticipates a net loss of $2 billion in the first quarter of 2020.

Zacks Equity Research

5 Healthcare Stocks Poised to Beat Earnings Estimates in Q1

Earnings results of healthcare sector are likely to reflect solid demand for its products and services from aging population and the growing incidence of COVID-19 illness.

    Zacks Equity Research

    O'Reilly (ORLY) to Post Q1 Earnings: What's in the Offing?

    Elevated SG&A costs, along with weak demand of vehicles due to the coronavirus outbreak, are likely to have eroded O'Reilly's (ORLY) margins in Q1.

    Zacks Equity Research

    PACCAR (PCAR) Gearing Up for Q1 Earnings: What to Expect?

    Low orders for Class 8 trucks due to the outbreak of coronavirus are likely to have dented PACCAR's (PCAR) first-quarter 2020 revenues.

    Sheraz Mian headshot

    Q1 Earnings Scorecard and Analyst Reports for Netflix, Costco & Others

    In addition to new research reports on 16 major stocks, including Netflix (NFLX), Costco (COST) and others, we also have real-time Q1 earnings scorecard today.

    Zacks Equity Research

    Cigna's (CI) New Solution to Boost Its Dental Care Services

    Cigna (CI) enhances its suite of dental care services with a virtual solution amid the pandemic. This is likely to help contain the virus spread.

    Zacks Equity Research

    What's in the Cards for UnitedHealth's (UNH) Q1 Earnings?

    UnitedHealth's (UNH) Q1 earnings results to reflect gain from increase in revenues and the effect of share buyback.

    Zacks Equity Research

    The Zacks Analyst Blog Highlights: Molina Healthcare, Cigna, UnitedHealth, Anthem and Humana

    The Zacks Analyst Blog Highlights: Molina Healthcare, Cigna, UnitedHealth, Anthem and Humana

    Zacks Equity Research

    7 Health Insurers Poised to Beat Earnings Estimates in Q1

    Health insurers are likely to gain from a solid revenue base, attributable to higher premiums across Medicare, Medicaid plans.

    Tirthankar Chakraborty headshot

    Sanders Gives Health Insurers a Boost: Spotlight on 5 Stocks

    Sanders' policies haven't been positive for health insurance stocks. He has favored Medicare-For-All and intended to abolish private insurance, which had cast a shadow on health insurance companies for months.

    Zacks Equity Research

    Will Cigna (CI) Beat Estimates Again in Its Next Earnings Report?

    Cigna (CI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.